retatrutide obesity trial Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more at our link in bio Retatrutide for weight loss: Study

Initial targets included compounding pharmacies like Strive and Empower, which Lilly accused of continuing to produce mass-manufactured tirzepatide while falsely marketing it as "personalized" medication

Nevertheless, understanding GI adverse events across both earlier and newer GLP-1based therapies remains highly relevant, particularly as these agents are increasingly prescribed for long-term and off-label indications

JoAnna Pendergrass, DVM, pets reporter: I'm a medical writer with a doctorate in veterinary medicine from the Virginia-Maryland College of Veterinary Medicine

Stahl predicted years ago: Depression is probably at least five different illnesses with the same symptom presentation